Limitations of radiolabeled monoclonal antibodies for localization of human neoplasms
Journal Article
·
· Cancer Res.; (United States)
OSTI ID:5688017
Tumor-associated monoclonal antibodies were radiolabeled with /sup 125/I and /sup 131/I and given i.v. in pairs to 19 patients 1-26 days prior to surgical excision of primary and metastatic breast, ovarian, and gastrointestinal tumors. For individual patients each monoclonal antibody was designated as specific or nonspecific according to prior immunoperoxidase staining results on the appropriate target neoplastic tissues. Quantitation of antibody uptake was performed on resected normal and neoplastic tissues. Although good tumor:non-tumor ratios were obtained with the specific antibodies (maximal tumor:blood ratio, 35.8:1 at 12 days postadministration), the absolute amount of radiolabel detected in tumors was small (mean value of 0.015% of total injected amount per g of tumor occurring 1 day postadministration). Furthermore, both specific and nonspecific antibodies accumulated in normal lymph nodes to a significant extent (mean value of 0.0026% of total injected amount per g of tissue occurring 1 day postadministration). Knowledge of such data is essential prior to considering therapeutic uses of radiolabeled monoclonal antibodies.
- Research Organization:
- Royal Postgraduate Medical School, London, England
- OSTI ID:
- 5688017
- Journal Information:
- Cancer Res.; (United States), Journal Name: Cancer Res.; (United States) Vol. 6; ISSN CNREA
- Country of Publication:
- United States
- Language:
- English
Similar Records
Intravesical administration of radiolabeled antitumor monoclonal antibody in bladder carcinoma
Localization of radioiodine conjugated to the monoclonal antibody HMFG2 in human ovarian carcinoma: assessment of intravenous and intraperitoneal routes of administration
Intracavitary use of two radiolabeled tumor-associated monoclonal antibodies
Journal Article
·
Mon Jan 14 23:00:00 EST 1991
· Cancer Research; (USA)
·
OSTI ID:6246411
Localization of radioiodine conjugated to the monoclonal antibody HMFG2 in human ovarian carcinoma: assessment of intravenous and intraperitoneal routes of administration
Journal Article
·
Tue Sep 01 00:00:00 EDT 1987
· Cancer Res.; (United States)
·
OSTI ID:6025919
Intracavitary use of two radiolabeled tumor-associated monoclonal antibodies
Journal Article
·
Wed Nov 30 23:00:00 EST 1988
· J. Nucl. Med.; (United States)
·
OSTI ID:6610814
Related Subjects
550901* -- Pathology-- Tracer Techniques
59 BASIC BIOLOGICAL SCIENCES
ANIMALS
ANTIBODIES
ANTIGENS
BETA DECAY RADIOISOTOPES
BETA-MINUS DECAY RADIOISOTOPES
BIOLOGICAL HALF-LIFE
BIOLOGICAL LOCALIZATION
BODY
DAYS LIVING RADIOISOTOPES
DIGESTIVE SYSTEM
DISEASES
ELECTRON CAPTURE RADIOISOTOPES
FEMALE GENITALS
GASTROINTESTINAL TRACT
GLANDS
GLOBULINS
GONADS
IMMUNOGLOBULINS
IMMUNOTHERAPY
INTERMEDIATE MASS NUCLEI
IODINE 125
IODINE 131
IODINE ISOTOPES
ISOTOPE APPLICATIONS
ISOTOPES
LABELLING
LYMPH NODES
LYMPHATIC SYSTEM
MAMMALS
MAMMARY GLANDS
METASTASES
MICE
MONOCLONAL ANTIBODIES
NEOPLASMS
NUCLEI
ODD-EVEN NUCLEI
ORGANIC COMPOUNDS
ORGANS
OVARIES
PATIENTS
PROTEINS
RADIOISOTOPES
RODENTS
THERAPY
TRACER TECHNIQUES
VERTEBRATES
59 BASIC BIOLOGICAL SCIENCES
ANIMALS
ANTIBODIES
ANTIGENS
BETA DECAY RADIOISOTOPES
BETA-MINUS DECAY RADIOISOTOPES
BIOLOGICAL HALF-LIFE
BIOLOGICAL LOCALIZATION
BODY
DAYS LIVING RADIOISOTOPES
DIGESTIVE SYSTEM
DISEASES
ELECTRON CAPTURE RADIOISOTOPES
FEMALE GENITALS
GASTROINTESTINAL TRACT
GLANDS
GLOBULINS
GONADS
IMMUNOGLOBULINS
IMMUNOTHERAPY
INTERMEDIATE MASS NUCLEI
IODINE 125
IODINE 131
IODINE ISOTOPES
ISOTOPE APPLICATIONS
ISOTOPES
LABELLING
LYMPH NODES
LYMPHATIC SYSTEM
MAMMALS
MAMMARY GLANDS
METASTASES
MICE
MONOCLONAL ANTIBODIES
NEOPLASMS
NUCLEI
ODD-EVEN NUCLEI
ORGANIC COMPOUNDS
ORGANS
OVARIES
PATIENTS
PROTEINS
RADIOISOTOPES
RODENTS
THERAPY
TRACER TECHNIQUES
VERTEBRATES